Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Clinical trial NCT04370301 · RECRUITING

Trial details

NCT number: NCT04370301
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2021-02-09
Primary completion: 2027-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.